EP300 and neoplasm: In line with the observations above, the other experiments testing glycolysis also showed that the EP300 deficiency is linked to a reduction in glucose uptake, LDH activity, and lactic acid production in tumor cells but increased extracellular glucose in the tumor microenvironment (TME) (Figure 7C–F).